These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1774431)

  • 61. Initial platelet serotonin (5-HT) transport kinetics predict nortriptyline treatment outcome.
    Rausch JL; Moeller FG; Johnson ME
    J Clin Psychopharmacol; 2003 Apr; 23(2):138-44. PubMed ID: 12640215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
    Kasper S; Dötsch M; Kick H; Vieira A; Möller HJ
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):13-21. PubMed ID: 8471827
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia.
    Jakovljević M; Mück-Seler D; Pivac N; Ljubicić D; Bujas M; Dodig G
    Biol Psychiatry; 1997 May; 41(10):1028-34. PubMed ID: 9129783
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High platelet-serotonin uptake activity is associated with a rapid response in depressed patients treated with amitriptyline.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Neurosci Lett; 2003 Jul; 345(2):105-8. PubMed ID: 12821182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
    Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
    Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet serotonin in essential hypertension and in mental depression.
    Baudouin-Legros M; Le Quan-Bui KH; Guicheney P; Kamal LA; Meyer P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S12-4. PubMed ID: 2412030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trazodone. A comparative clinical and predictive study.
    Kerr TA; McClelland HA; Stephens DA; Ankier SI
    Acta Psychiatr Scand; 1984 Dec; 70(6):573-7. PubMed ID: 6395636
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thyroid hormones, body temperature, and antidepressant treatment.
    Höflich G; Kasper S; Danos P; Schmidt R
    Biol Psychiatry; 1992 Apr; 31(8):859-62. PubMed ID: 1643199
    [No Abstract]   [Full Text] [Related]  

  • 69. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical use of the determination of serotonin in whole blood.
    Kremer HP; Goekoop JG; Van Kempen GM
    J Clin Psychopharmacol; 1990 Apr; 10(2):83-7. PubMed ID: 2111336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trazodone in the treatment of neurotic depression.
    Goldberg HL; Finnerty RJ
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 1):430-4. PubMed ID: 7440519
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monoamine transport in depression: kinetics and dynamics.
    Healy D; Leonard BE
    J Affect Disord; 1987; 12(2):91-103. PubMed ID: 3036923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study.
    Lamping DL; Spring B; Gelenberg AJ
    Psychopharmacology (Berl); 1984; 84(2):254-61. PubMed ID: 6438686
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of amoxapine on serotonin uptake in human blood platelets of depressed patients and normal controls.
    Arora RC; Meltzer HY
    Psychiatry Res; 1983 May; 9(1):29-36. PubMed ID: 6577482
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monoamine-related markers of depression: changes following treatment.
    Healy D; Carney PA; Leonard BE
    J Psychiatr Res; 1982-1983; 17(3):251-60. PubMed ID: 6821276
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trazodone and amitriptyline in treatment of depressed inpatients. A double-blind study.
    Moises HW; Kasper S; Beckmann H
    Pharmacopsychiatria; 1981 Sep; 14(5):167-71. PubMed ID: 7027279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.